ICON plc is a Dublin-based clinical research organization providing outsourced development services to pharmaceutical, biotechnology, and medical device industries, employing 41,100 people. Their specialized services expedite the market entry of new drugs and devices.
Icon Plc (ICLR) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Icon Plc's actual EPS was $3.35, beating the estimate of $3.91 per share, resulting in a 16.83% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!